The disease management industry, which focuses on reducing or delaying the use of expensive treatments or costly procedures, has passed its prime as a unique approach to controlling escalating costs attributed to chronic conditions. It worked on the sickest of the sick, but as patient conditions progressed and engagement levels decreased, it gradually lost its effectiveness. The industry hit a growth ceiling when health clients no longer found that cost savings justified the high care management fees charged by DM companies.
The Technological Evolution of US Healthcare
Posted by: Harry Wang March 7, 2016 11:42 AMThe disease management industry, which focuses on reducing or delaying the use of expensive treatments or costly procedures, has passed its prime as a unique approach to controlling escalating costs attributed to chronic conditions. It worked on the sickest of the sick, but as patient conditions progressed and engagement levels decreased, it gradually lost its effectiveness. The industry hit a growth ceiling when health clients no longer found that cost savings justified the high care management fees charged by DM companies.